I  Virginia Biosciences Commercialization Center (VBCC)

http://vbcc-inc.com





     Office Locations:

800 East Leigh Street
Richmond, VA 23219
Phone: 804-677-2985

 

Stages:

  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    The Virginia Biosciences Commercialization Center (VBCC) develops and leads implementation of tailored commercialization strategies for later-stage bioscience companies looking to launch their product(s) in U.S. markets. This comprehensive program surrounds each company with scientific, clinical and industry experts focused on every facet of the commercialization process, assuring effective scale-up and maximization of enterprise value. Virginia Life Sciences Investments (VLSI), the Commercialization Center's parent company, can provide financial support for realization of significant commercialization milestones. VLSI's primary focus is on medical device and diagnostic companies that provide a significantly more effective and cost-efficient solution to the market.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Donna J. Edmonds Chief Executive Officer
    Idan Tamir Executive Leadership and Special Projects
    Nazanin Mirshahi Marketing and Business Development Manager
    Paul F. Rocheleau Chairman of the Board & Chief Investment Officer
    Timothy Black Chief Financial Officer

     

    Portfolio companies include:


      BioCancell Therapeutics
        web link


      BioProtect
        web link


      Cupron
        web link


      Faneuil Medical
        web link


      Gardia Medical
        web link


      ImmunArray
        web link


      NeatStitch
        web link


      OrthoSpace
        web link


      Virtual Ports
        web link


      Xenolith Medical
        web link


     

    Recent News: